Gary S. Gillheeney serves as President and CEO of Organogenesis Holdings Inc. (ORGO). Gillheeney has reported 6 insider filings with the SEC since 2024. The most recent filing was in March 2026.
Every role Gary S. Gillheeney has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Organogenesis Holdings Inc. (ORGO)6 filingsUpdated Aug 31, 2026
Gary S. Gillheeney is President and CEO, Director of Organogenesis Holdings Inc. (ORGO). 6 SEC Form 4 filings on record going back to 2024, most recently on 3 March 2026. Most recent open-market trade: sold $19K of ORGO on 16 December 2024. Lifetime open-market sales: $1.36M.
Every recent SEC Form 4 transaction Gary S. Gillheeney has reported, most recent first.
InsiderAlpha's records for Gary S. Gillheeney go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Gary S. Gillheeney files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Gary S. Gillheeney is a corporate insider, tracked as President and CEO, Director of Organogenesis Holdings Inc. (ORGO). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 3 March 2026, one of 6 filings going back to 2024.
Recorded transactions: 0 open-market purchases and 7 open-market sales ($1.36M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$ORGO Organogenesis Holdings Inc.90.4K shares @ $3.84$347K